|
|
|
Insider
Information: |
Lawlor Augustine |
Relationship: |
Chief Operating Officer |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
3,659,632 |
|
Indirect Shares
|
2,634,390 |
|
|
Direct
Value |
$26,500 |
|
|
Indirect Value
|
$2,748,145 |
|
|
Total
Shares |
6,294,022 |
|
|
Total
Value |
$2,774,645 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
0.0%
|
-7.1%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Middlebrook Pharmaceuticals Corp |
MBRKQ |
10% Owner |
2003-10-22 |
3,629,973 |
2003-10-22 |
0 |
Premium* |
|
Human Genome Sciences Inc |
HGSI |
Director |
2012-07-30 |
0 |
|
0 |
Premium* |
|
Replidyne Inc |
RDYN |
Director |
2023-04-27 |
0 |
2023-04-27 |
0 |
Premium* |
|
Molecular Templates, Inc. |
MTEM |
10% Owner |
|
0 |
2008-08-29 |
1,470,588 |
Premium* |
|
Gyre Therapeutics |
GYRE |
Director |
2021-10-01 |
24,573 |
2021-10-01 |
24,215 |
Premium* |
|
Globeimmune Inc |
GBIM |
Director |
2016-02-22 |
0 |
2016-03-18 |
463,267 |
Premium* |
|
Leap Therapeutics, Inc. |
LPTX |
Chief Operating Officer |
2024-01-26 |
5,086 |
2024-01-26 |
676,320 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
81 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
HGSI |
Human Genome Sciences Inc |
Director |
|
2004-03-03 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,311 |
|
- |
|
MTEM |
Molecular Templates, Inc. |
10% Owner |
|
2008-08-29 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,470,588 |
|
- |
|
LPTX |
Leap Therapeutics, Inc. |
Chief Operating OfficerOfficer |
|
2017-01-20 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,477,902 |
|
- |
|
MBRKQ |
Middlebrook Pharmaceutica... |
10% Owner |
|
2003-10-22 |
4 |
A |
$0.00 |
$0 |
D/D |
3,629,973 |
3,629,973 |
|
- |
|
RDYN |
Replidyne Inc |
Director |
|
2006-07-03 |
4/A |
A |
$0.00 |
$0 |
I/I |
3,869,796 |
4,359,069 |
|
- |
|
RDYN |
Replidyne Inc |
Director |
|
2006-07-03 |
4 |
A |
$0.00 |
$0 |
I/I |
3,869,796 |
4,212,628 |
|
- |
|
HGSI |
Human Genome Sciences Inc |
Director |
|
2007-07-11 |
4 |
A |
$0.00 |
$0 |
D/D |
611 |
2,022 |
0 |
- |
|
HGSI |
Human Genome Sciences Inc |
Director |
|
2011-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
34,446 |
0 |
- |
|
RDYN |
Replidyne Inc |
Director |
|
2011-08-08 |
4 |
A |
$0.00 |
$0 |
D/D |
3,596 |
3,596 |
0 |
- |
|
HGSI |
Human Genome Sciences Inc |
Director |
|
2012-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
44,891 |
0 |
- |
|
RDYN |
Replidyne Inc |
Director |
|
2012-08-31 |
4 |
A |
$0.00 |
$0 |
D/D |
5,459 |
9,055 |
0 |
- |
|
RDYN |
Replidyne Inc |
Director |
|
2013-08-13 |
4 |
A |
$0.00 |
$0 |
D/D |
2,290 |
11,345 |
0 |
- |
|
RDYN |
Replidyne Inc |
Director |
|
2014-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
215 |
11,560 |
0 |
- |
|
RDYN |
Replidyne Inc |
Director |
|
2014-08-11 |
4 |
A |
$0.00 |
$0 |
D/D |
2,045 |
13,605 |
0 |
- |
|
RDYN |
Replidyne Inc |
Director |
|
2015-08-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,541 |
16,146 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
Director |
|
2015-08-20 |
4 |
A |
$0.00 |
$0 |
I/I |
1,041,024 |
1,041,024 |
0 |
- |
|
RDYN |
Replidyne Inc |
Director |
|
2016-08-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,855 |
19,001 |
0 |
- |
|
RDYN |
Replidyne Inc |
Director |
|
2017-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
130 |
19,131 |
0 |
- |
|
RDYN |
Replidyne Inc |
Director |
|
2017-02-22 |
4 |
D |
$0.00 |
$0 |
I/I |
(74,670) |
0 |
0 |
- |
|
RDYN |
Replidyne Inc |
Director |
|
2017-08-07 |
4 |
A |
$0.00 |
$0 |
D/D |
2,417 |
21,548 |
0 |
- |
|
RDYN |
Replidyne Inc |
Director |
|
2018-08-28 |
4 |
A |
$0.00 |
$0 |
D/D |
1,960 |
23,508 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
Director |
|
2018-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
2,732 |
2,732 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
Director |
|
2019-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,414 |
5,146 |
0 |
- |
|
GYRE |
Gyre Therapeutics |
Director |
|
2019-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,905 |
8,051 |
0 |
- |
|
RDYN |
Replidyne Inc |
Director |
|
2019-08-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,810 |
25,318 |
0 |
- |
|
81 Records found
|
|
Page 1 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|